trending Market Intelligence /marketintelligence/en/news-insights/trending/rql6slzni_tefph37r92eg2 content esgSubNav
In This List

Advanced Proteome Therapeutics names CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Advanced Proteome Therapeutics names CEO

Advanced Proteome Therapeutics Corp. appointed Bill Dickie CEO, president and director, effective June 6.

The appointment comes after Randal Chase resigned as president, CEO and director of the biotechnology company in April.

Dickie previously served as president, CEO and director of Atreus Pharmaceuticals, a radiopharmaceutical development company. He has also served as the president, CEO and director of Liponex Inc.